Amgen (AMGN)
(Delayed Data from NSDQ)
$311.29 USD
+32.90 (11.82%)
Updated May 3, 2024 04:00 PM ET
After-Market: $311.41 +0.12 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 1 - 20 ( 427 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 2124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 12124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 11124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 1124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 122123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for AMGN 12123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department